Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region

Merry J Markham, MD, FACP FASCO : Research

Cancer Specialist (Oncologist), Hematologist (Blood Disease Specialist), Hematology and Oncology Specialist

Photo of Merry J Markham

Research at a glance

Top areas of exploration

  • Medical Oncology , 22 publications
  • Neoplasms , 16 publications
  • Communication , 7 publications
  • Antineoplastic Combined Chemotherapy Protocols , 5 publications

Research activity

106 publications

1,173 citations

Why is this important?

Focus

Dr. Markham focuses her clinical expertise and investigations on gynecologic malignancies. She serves as the Program Leader for the multidisciplinary Gynecologic Oncology Program at UF and the Research Lead for the UF Health Cancer Center's Gynecologic Cancers Disease Site Group. Highly involved in medical education, Dr. Markham has been a medical school course director and is a frequent lecturer in the College of Medicine. She serves as a mentor and teacher of medical students, residents, and hematology-oncology fellows in the Department of Medicine, and she has received numerous awards for her teaching activities. Dr. Markham's research interests include - experimental therapeutics and prognostic factors for gynecological malignancies; quality of cancer care and quality improvement strategies; and cancer communications, including the role of social media in medicine, patient education, patient decision making and empowerment, and medical education.

Active clinical trials

My publications

106 publications

2024

Tele-Oncology Use During the COVID-19 Pandemic: Patient Experiences and Communication Behaviors with Clinicians.

Telemedicine journal and e-health : the official journal of the American Telemedicine Association

PubMed Publisher's site

2023

A nurse-led intervention in patients with newly diagnosed cancer and Type 2 diabetes: A pilot randomized controlled trial feasibility study.

Cancer medicine

PubMed Publisher's site

2023

Are evaluations in simulated medical encounters reliable among rater types? A comparison between standardized patient and outside observer ratings of OSCEs.

PEC innovation

PubMed Publisher's site

2023

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study.

eLife

PubMed Publisher's site

2023

Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study.

medRxiv : the preprint server for health sciences

PubMed Publisher's site